Expression of the interleukin-1 receptor antagonist associates with patient survival in high-grade serous ovarian cancer.
Keyword(s):
Ovarian cancer is the most lethal gynecologic cancer (1). We sought to identify genes associated with enhanced survival in high-grade serous ovarian cancer (HGSC) by comparing global gene expression profiles of tumors from women diagnosed with HGSC with the best and worst progression-free survival (2). We found significant differential expression of the gene encoding the receptor antagonist for the cytokine interleukin-1 (IL-1) (IL-1RN) when comparing tumor transcriptomes based on progression-free survival. IL-1RN was expressed at significantly lower levels in high-grade serous ovarian tumors of women with the longest progression-free survival.
2020 ◽
2020 ◽
2020 ◽
2020 ◽
2020 ◽
Keyword(s):
2021 ◽
2021 ◽
2020 ◽
2021 ◽